Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Platelet Rich Plasma Lysate for Diabetic Foot Ulcer
NCT02972528Phase 2Unknown
- Start
- Feb 2018
- Primary completion
- Feb 2020
- Modality
- Blood Coagulation Factors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of platelet lysate in diabetic foot ulcer (DFU) (2 arms). Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 3 months. Status: unknown.
02
Drugs
platelet lysate
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02972528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972528.